Unknown

Dataset Information

0

Systematic Analysis of Transcriptomic Profile of the Effects of Low Dose Atropine Treatment on Scleral Fibroblasts using Next-Generation Sequencing and Bioinformatics.


ABSTRACT: This study has two novel findings: it is not only the first to deduct potential genes involved in scleral growth repression upon atropine instillation from a prevention point of view, but also the first to demonstrate that only slight changes in scleral gene expression were found after atropine treatment as side effects and safety reasons of the eye drops are of concern. The sclera determines the final ocular shape and size, constituting of scleral fibroblasts as the principal cell type and the major regulator of extracellular matrix. The aim of our study was to identify differentially expressed genes and microRNA regulations in atropine-treated scleral fibroblasts that are potentially involved in preventing the onset of excessive ocular growth using next-generation sequencing and bioinformatics approaches. Differentially expressed genes were functionally enriched in anti-remodeling effects, comprising of structural changes of extracellular matrix and metabolic pathways involving cell differentiation. Significant canonical pathways were correlated to inhibition of melatonin degradation, which was compatible with our clinical practice as atropine eye drops are instilled at night. Validation of the dysregulated genes with previous eye growth-related arrays and through microRNA-mRNA interaction predictions revealed the association of hsa-miR-2682-5p-KCNJ5 and hsa-miR-2682-5p-PRLR with scleral anti-remodeling and circadian rhythmicity. Our findings present new insights into understanding the anti-myopic effects of atropine, which may assist in prevention of myopia development.

SUBMITTER: Hsiao YT 

PROVIDER: S-EPMC6909806 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systematic Analysis of Transcriptomic Profile of the Effects of Low Dose Atropine Treatment on Scleral Fibroblasts using Next-Generation Sequencing and Bioinformatics.

Hsiao Yu-Ting YT   Chang Wei-An WA   Kuo Ming-Tse MT   Lo Jung J   Lin Hsien-Chung HC   Yen Meng-Chi MC   Jian Shu-Fang SF   Chen Yi-Jen YJ   Kuo Po-Lin PL  

International journal of medical sciences 20191109 12


This study has two novel findings: it is not only the first to deduct potential genes involved in scleral growth repression upon atropine instillation from a prevention point of view, but also the first to demonstrate that only slight changes in scleral gene expression were found after atropine treatment as side effects and safety reasons of the eye drops are of concern. The sclera determines the final ocular shape and size, constituting of scleral fibroblasts as the principal cell type and the  ...[more]

Similar Datasets

| S-EPMC6306862 | biostudies-literature
| S-EPMC5751259 | biostudies-literature
| S-EPMC6089098 | biostudies-literature
| S-EPMC7031678 | biostudies-literature
| S-EPMC6097257 | biostudies-literature
2017-04-03 | PXD003804 | Pride
| S-EPMC3633008 | biostudies-literature
| S-EPMC6462954 | biostudies-literature
| S-EPMC3570555 | biostudies-literature
2018-12-18 | GSE110606 | GEO